News from Johnson & Johnson
Stay current with all the latest and breaking news about Johnson & Johnson, compare headlines and perspectives between news sources on stories happening today. In total, 144 stories have been published about Johnson & Johnson which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Johnson & Johnson News
Latest News Stories
Cancer · ChicagoJohnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies' baby powders for giving her a fatal cancer in what was the first verdict against the J&J spinoff in a decade-long litigation over the product. Jurors hearing the case in Chicago late Friday concluded Kenvue was 70% responsible for the death of Theresa Garcia, a mother of six and a grandmother, who died in 2020 after deve…See the Story
Johnson & Johnson To Pay Millions To Woman Who Blamed Baby Powder For Cancer
100% Left coverage: 1 sources
Johnson & Johnson · IndiaJohnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies’ baby powders for giving her a fatal cancer in what was the first verdict against the J&J spinoff in a decade-long litigation over the product.See the Story
J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s Family
100% Center coverage: 2 sources
World Health Organization · HungaryThe World Health Organization (WHO) is expected to issue a warning over one of Johnson and Johnson's (J&J) cough syrups because toxic compounds have been found in Nigerian stockpiles of the drug, the UN agency said on Friday.See the Story
Toxic compounds found in a popular children's drug
Johnson & Johnson · Port HuronHealth News Roundup: J&J wins trial over Florida woman who claimed its baby powder caused her cancer; German watchdog approves Novo's acquisition of Cardior Pharmaceuticals and more Following is a summary of current health news briefs.J&J wins trial over Florida woman who claimed its baby powder caused her cancerA Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida w…See the Story
Health News Roundup: J&J wins trial over Florida woman who claimed its baby powder caused her cancer; German watchdog approves Novo's acquisition of Cardior Pharmaceuticals and more
100% Center coverage: 1 sources
Johnson & JohnsonOn Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion. Operational growth was 3.9%, and adjusted operational growth was 4.0%. After good earnings results, Cantor Fitzgerald remains positive on Johnson & Johnson’s stock. The analyst…See the Story
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future - Johnson & Johnson (NYSE:JNJ)
100% Center coverage: 1 sources
Johnson & Johnson · TorontoTORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- TRC Capital Investment Corporation (TRC) announced today that based on current market conditions, TRC has amended the terms of its tender offer for up to 1,000,000 common shares of Johnson & Johnson (the Company) and has decreased the offer price payable to US$142.88 per share from US$151.23 per share. TRC also announced that its offer will still expire at 12:01 a.m. New York City time on May 2, 2024…See the Story
TRC Amends Its Tender Offer for Johnson & Johnson
100% Center coverage: 1 sources
Johnson & Johnson · New BrunswickJohnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. The company posted adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion, according to data from Benzinga Pro. Johnson & Johnson also raised its quarterly dividend by 4.2% from $1.19 per share to $1.24…See the Story
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results - Johnson & Johnson (NYSE:JNJ)
100% Center coverage: 1 sources